List of Excipients in API guaifenesin and dextromethorphan hydrobromide
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing guaifenesin and dextromethorphan hydrobromide
Excipients in ANDA-approved (generic) drugs containing guaifenesin and dextromethorphan hydrobromide
Detailed excipient profiles for guaifenesin and dextromethorphan hydrobromide
Excipient focus: ALUMINUM OXIDE
guaifenesin and dextromethorphan hydrobromide drug variants containing ALUMINUM OXIDE
guaifenesin and dextromethorphan hydrobromide drug variants not containing ALUMINUM OXIDE
Excipient focus: CARBOMER 934
guaifenesin and dextromethorphan hydrobromide drug variants containing CARBOMER 934
| Company | Ingredient | NDC |
|---|---|---|
| Physicians Total Care Inc | guaifenesin and dextromethorphan hydrobromide | 54868-5853 |
| Physicians Total Care Inc | guaifenesin and dextromethorphan hydrobromide | 54868-6106 |
| >Company | >Ingredient | >NDC |
guaifenesin and dextromethorphan hydrobromide drug variants not containing CARBOMER 934
Excipient focus: CARBOMER HOMOPOLYMER TYPE B
guaifenesin and dextromethorphan hydrobromide drug variants containing CARBOMER HOMOPOLYMER TYPE B
guaifenesin and dextromethorphan hydrobromide drug variants not containing CARBOMER HOMOPOLYMER TYPE B
| Company | Ingredient | NDC |
|---|---|---|
| Physicians Total Care Inc | guaifenesin and dextromethorphan hydrobromide | 54868-5853 |
| Physicians Total Care Inc | guaifenesin and dextromethorphan hydrobromide | 54868-6106 |
| >Company | >Ingredient | >NDC |
Excipient focus: CELLULOSE, MICROCRYSTALLINE
guaifenesin and dextromethorphan hydrobromide drug variants containing CELLULOSE, MICROCRYSTALLINE
guaifenesin and dextromethorphan hydrobromide drug variants not containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: D&C YELLOW NO. 10
guaifenesin and dextromethorphan hydrobromide drug variants containing D&C YELLOW NO. 10
guaifenesin and dextromethorphan hydrobromide drug variants not containing D&C YELLOW NO. 10
Excipient focus: HYPROMELLOSE
guaifenesin and dextromethorphan hydrobromide drug variants containing HYPROMELLOSE
guaifenesin and dextromethorphan hydrobromide drug variants not containing HYPROMELLOSE
| Company | Ingredient | NDC |
|---|---|---|
| ATLANTIC BIOLOGICALS CORP | guaifenesin and dextromethorphan hydrobromide | 17856-0056 |
| >Company | >Ingredient | >NDC |
Excipient focus: HYPROMELLOSES
guaifenesin and dextromethorphan hydrobromide drug variants containing HYPROMELLOSES
| Company | Ingredient | NDC |
|---|---|---|
| ATLANTIC BIOLOGICALS CORP | guaifenesin and dextromethorphan hydrobromide | 17856-0056 |
| >Company | >Ingredient | >NDC |
guaifenesin and dextromethorphan hydrobromide drug variants not containing HYPROMELLOSES
Excipient focus: MAGNESIUM STEARATE
guaifenesin and dextromethorphan hydrobromide drug variants containing MAGNESIUM STEARATE
guaifenesin and dextromethorphan hydrobromide drug variants not containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: MALTODEXTRIN
guaifenesin and dextromethorphan hydrobromide drug variants containing MALTODEXTRIN
| Company | Ingredient | NDC |
|---|---|---|
| RITE-AID | guaifenesin and dextromethorphan hydrobromide | 11822-9996 |
| CVS PHARMACY INC | guaifenesin and dextromethorphan hydrobromide | 51316-600 |
| SAM'S WEST INC | guaifenesin and dextromethorphan hydrobromide | 68196-997 |
| >Company | >Ingredient | >NDC |
guaifenesin and dextromethorphan hydrobromide drug variants not containing MALTODEXTRIN
Excipient focus: POVIDONE K30
guaifenesin and dextromethorphan hydrobromide drug variants containing POVIDONE K30
| Company | Ingredient | NDC |
|---|---|---|
| RITE-AID | guaifenesin and dextromethorphan hydrobromide | 11822-9996 |
| CVS PHARMACY INC | guaifenesin and dextromethorphan hydrobromide | 51316-600 |
| SAM'S WEST INC | guaifenesin and dextromethorphan hydrobromide | 68196-997 |
| >Company | >Ingredient | >NDC |
guaifenesin and dextromethorphan hydrobromide drug variants not containing POVIDONE K30
Excipient focus: SILICON DIOXIDE
guaifenesin and dextromethorphan hydrobromide drug variants containing SILICON DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| RITE-AID | guaifenesin and dextromethorphan hydrobromide | 11822-9996 |
| CVS PHARMACY INC | guaifenesin and dextromethorphan hydrobromide | 51316-600 |
| SAM'S WEST INC | guaifenesin and dextromethorphan hydrobromide | 68196-997 |
| >Company | >Ingredient | >NDC |
guaifenesin and dextromethorphan hydrobromide drug variants not containing SILICON DIOXIDE
Excipient focus: SODIUM STARCH GLYCOLATE TYPE A POTATO
guaifenesin and dextromethorphan hydrobromide drug variants containing SODIUM STARCH GLYCOLATE TYPE A POTATO
guaifenesin and dextromethorphan hydrobromide drug variants not containing SODIUM STARCH GLYCOLATE TYPE A POTATO
Excipient focus: STEARIC ACID
guaifenesin and dextromethorphan hydrobromide drug variants containing STEARIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| RITE-AID | guaifenesin and dextromethorphan hydrobromide | 11822-9996 |
| CVS PHARMACY INC | guaifenesin and dextromethorphan hydrobromide | 51316-600 |
| SAM'S WEST INC | guaifenesin and dextromethorphan hydrobromide | 68196-997 |
| >Company | >Ingredient | >NDC |
guaifenesin and dextromethorphan hydrobromide drug variants not containing STEARIC ACID
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
© Copyright 2002-2024 thinkBiotech LLC
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - HIPAA-ready chat for life sciences
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - HIPAA-ready chat for life sciences
Preferred Citation:
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Links
Follow DrugPatentWatch:
